During the past decade, TATA Medical Centre; Medical Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "TATA Medical Centre; Medical Oncology" are "Breast Cancer" (2 trials), "Triple-Negative Breast Cancer" (1 trials) and "Urinary Tract Cancer" (1 trials). Many other conditions were trialed in "TATA Medical Centre; Medical Oncology" in a lesser frequency.

Most popular intervention types in "TATA Medical Centre; Medical Oncology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Trastuzumab" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "TATA Medical Centre; Medical Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "TATA Medical Centre; Medical Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in TATA Medical Centre; Medical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TATA Medical Centre; Medical Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".